• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AI Tool Classifies Thyroid Nodule Samples by Bethesda System with High Test Accuracy

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
AI Tool Classifies Thyroid Nodule Samples by Bethesda System with High Test Accuracy

AI Tool Classifies Thyroid Nodule Samples by Bethesda System with High Test Accuracy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers in eastern India have built and publicly released a deep-learning tool, CytoThyro AI, that automatically classifies thyroid fine-needle aspiration cytology (FNAC) images according to the six-category 2023 Bethesda System for Reporting Thyroid Cytopathology. In a prospective study of 175 patients, the Pap-stain-based model ensemble reached a patient-level classification accuracy of 96 percent (26 of 27 patients) on a held-out test set, while a parallel pipeline built on May-Grünwald Giemsa (MGG) stains achieved 89 percent (24 of 27). The work, published open access in Diagnostic Pathology, addresses a practical bottleneck: thyroid FNAC is the standard first investigation for thyroid nodules, but reporting is subject to inter-observer variability, subjectivity and shortages of cytopathologists.

The study team acquired digital microphotographs in both MGG and Papanicolaou stains at 10X and 40X magnifications, generating 3,500 images in total. Bethesda category labels from B1 to B6 were assigned by majority consensus of three blinded cytopathologists, meaning the reference standard was cytological rather than histopathological. Five convolutional neural network architectures were trained with patient-level data partitioning in a 70:15:15 split, so that images from the same patient never appeared in both training and evaluation sets. Final models were chosen using the 2023 Bethesda clinical safety criteria and then combined into a weighted soft-voting ensemble, which was deployed as a publicly accessible web tool at cytothyro.cloud, intended at this stage for research and educational exploration.

Performance details highlight both the promise and the limits of the approach. The Pap-based ensemble achieved a macro F1 score of 0.94 and a weighted F1 of 0.96, with patient-level recall of 1.00 for categories B1, B2, B4, B5 and B6 but only 0.50 for B3. The MGG-based ensemble scored 89 percent accuracy with macro F1 of 0.85 and weighted F1 of 0.88, showing recall of 1.00 for B1 through B4, 0.33 for B5 and 0.80 for B6. The authors note that the category-specific recalls of 1.00 rest on between two and thirteen patients per category and therefore carry wide confidence intervals; the reported 95 percent confidence interval for the Pap pipeline’s accuracy spans 0.82 to 0.99, and for the MGG pipeline 0.72 to 0.96.

The most challenging category was B3, Atypia of Undetermined Significance. At the image level, AUC values for B3 ranged from 0.64 to 0.97 across models, with image-level F1 scores between 0.31 and 0.71. By contrast, the four selected models performed strongly on the clearer categories: image-level AUCs reached 1.00 for B1, ranged from 0.95 to 0.99 for B2, from 0.81 to 1.00 for B4, and from 0.91 to 1.00 for B6. Importantly, from a patient-safety standpoint, neither pipeline produced any B1/B2-to-B5/B6 misclassification at the patient level, meaning benign and malignant-suspicion categories were never confused in the test set.

Several caveats frame the findings. The test set comprised only 27 patients, the reference standard was consensus cytology rather than surgical histopathology, and the study population came from a single region of eastern India. The researchers position CytoThyro AI as a research and educational tool at this stage, not a diagnostic device for patient care. Even so, the study combined prospective image collection, patient-level data splitting, dual staining protocols and a safety-oriented model selection strategy, and the authors position CytoThyro AI as a research and educational tool at this stage.

Subject of Research: Deep learning classification of thyroid fine-needle aspiration cytology images according to the 2023 Bethesda System

Article Title: CytoThyro AI: automated classification of thyroid FNAC images using deep learning based on 2023 Bethesda System for reporting thyroid cytopathology

Article References: Dalal, B. S., Roy, D., Chakrabarti, I., Mondal, S. K., Mazumder, S., Munshi, B. D., Pal, B., Mallick, A., Gon, S., & Mukhopadhyay, K. (2026). CytoThyro AI: automated classification of thyroid FNAC images using deep learning based on 2023 Bethesda System for reporting thyroid cytopathology. Diagnostic Pathology. https://doi.org/10.1186/s13000-026-01862-z

Image Credits: AI Generated

DOI: 10.1186/s13000-026-01862-z

Keywords: thyroid cytology, FNAC, deep learning, Bethesda System 2023, convolutional neural networks, CytoThyro AI, diagnostic pathology, Papanicolaou stain, May-Grünwald Giemsa, AI-assisted diagnosis, inter-observer variability, prospective study

News Source: Ophelia Keating. (October 29, 2026). AI Tool Classifies Thyroid Nodule Samples by Bethesda System with High Test Accuracy. Scienmag.

Tags: AI-assisted diagnosisBethesda System 2023convolutional neural networksCytoThyro AIdeep learningdiagnostic pathologyFNACinter-observer variabilityMay-Grünwald GiemsaPapanicolaou stainprospective studythyroid cytology
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.